Research Productivity and Commercialization

funding piechart image

Research Funding & Scholarly Activity

The faculty of the College of Pharmacy is nationally renowned for its contributions to basic and applied research. Recently, the College’s Department of Clinical Pharmacy ranked as the 2nd most published clinical pharmacy faculty among US colleges of pharmacy (Pharm Pract 2007; 5(4):151-156).

In fiscal year 2008, College of Pharmacy faculty published 209 peer-reviewed publications, 96 books and book chapters, 116 abstracts and gave 119 invited presentations.

The College research enterprise is supported by a balanced funding portfolio of federal, industrial and foundation-based funding sources. Research expenditures from external sources amounted to more than $4 million in fiscal year 2008.

Patents & Licensing

In the period of 2004-2009, College faculty disclosed 51 inventions to the University of Tennessee Research Foundation. These disclosures resulted in 64 U.S. and international patents issued or pending. Twelve of the patented technologies have been licensed to industrial partners.

One of the most advanced projects that have originated in the research laboratories of the College of Pharmacy is the Selective Androgen Receptor Modulator (SARM) technology (Drs. Miller and Dalton) that has been licensed through the University of Tennessee Research Foundation to GTx, Inc, a Memphis-based biopharmaceutical company. The lead drug from this technology is currently in advanced clinical testing and is co-developed as Ostarine™ (MK-2866) by GTx, Inc and Merck & Co as a new medication for the treatment of sarcopenia and cancer cachexia.

Helix drawing

Contact Us

Wei Li, PhD
Professor and Faculty Director of Instrument Facility
University of Tennessee Health Science Center
881 Madison Avenue, room 561
Memphis, TN 38163
(901) 448-7532 (office)

Dejian Ma, PhD
Senior Research Specialist
University of Tennessee Health Science Center
881 Madison Avenue, room B024A
Memphis TN 38163
Phone: (901) 448-7376